만성 창상관리 시장 - 예측(2026-2031년)

The chronic wound care market is projected to expand at a 4.25% CAGR, attaining USD 16.894 billion in 2031 from USD 13.162 billion in 2025.

The chronic wound care market represents a critical and expanding segment within the global medical device and advanced therapy sector, focused on the management of wounds that fail to progress through the normal stages of healing. These wounds, which include diabetic foot ulcers, venous leg ulcers, pressure ulcers, and arterial ulcers, present a significant clinical and economic burden due to their complex pathophysiology, high recurrence rates, and association with underlying comorbidities. The market encompasses a wide range of products and therapies, from advanced wound dressings and bioactive agents to negative pressure wound therapy (NPWT) devices and emerging regenerative medicine solutions. Growth is fundamentally driven by powerful, non-cyclical demographic and epidemiological trends.

Primary Market Growth Drivers

The expansion of the market is underpinned by several powerful and interrelated demographic and disease factors. A primary driver is the global rise in the prevalence of diabetes mellitus. Diabetic foot ulcers (DFUs) are a severe and costly complication, with a high lifetime risk for patients. The pathophysiological triad of neuropathy, ischemia, and susceptibility to infection creates a challenging healing environment, driving sustained demand for specialized offloading devices, antimicrobial dressings, growth factors, and other advanced interventions aimed at preventing progression to amputation.

This is compounded by the worldwide aging of the population. Older adults are at exponentially higher risk for developing chronic wounds due to factors such as reduced mobility (leading to pressure injuries), decreased tissue perfusion, and higher rates of comorbid conditions like venous insufficiency. The demographic shift towards larger elderly populations directly correlates with increased incidence of venous leg ulcers and pressure injuries, ensuring a growing patient pool requiring long-term, often multi-modal, wound management.

Furthermore, the presence of multiple underlying systemic conditions contributes significantly to the patient burden. Chronic wounds frequently arise as secondary complications in individuals with conditions that impair immune function, circulation, or tissue integrity. This includes patients with cardiovascular diseases, cancer (and its treatments), autoimmune disorders, and renal failure. The management of these wounds is integral to the overall care of patients with complex, multi-system diseases, making wound care a cross-disciplinary clinical challenge.

Key Market Restraint

A significant constraint on market growth and patient access is the high cost associated with advanced wound care products and therapies. Advanced dressings, NPWT systems, skin substitutes, and cellular therapies involve substantial material and technology costs. This financial burden can limit adoption in cost-sensitive healthcare systems, create access disparities, and pose challenges for reimbursement. The economic pressure necessitates robust clinical evidence demonstrating that these advanced interventions lead to superior outcomes, such as faster healing times, reduced infection rates, and lower long-term costs through avoided hospitalizations and surgeries, to justify their expenditure.

Geographical Outlook: North American Market Strength

North America is expected to hold a significant share of the global chronic wound care market. This position is supported by a confluence of factors: a well-established healthcare infrastructure with high adoption rates of advanced medical technologies, a large and growing population of aging adults and individuals with diabetes, and a relatively favorable reimbursement environment for innovative wound care products compared to many other regions. Additionally, the presence of many leading medical device and biotechnology companies within the region drives continuous research, development, and commercialization of new solutions, further consolidating its market leadership.

Competitive Landscape and Innovation Focus

The market is served by a diverse group of players, including large multinational medical device corporations, specialized wound care companies, and biotechnology firms. Competition is based on product efficacy, clinical evidence, ease of use for clinicians and patients, and the strength of distributor networks. Strategic innovation is directed toward several key areas:

• Advanced Bioactive Dressings: Development of next-generation dressings that actively modulate the wound microenvironment with sustained antimicrobial activity, protease modulation, and growth factor delivery.
• Regenerative Medicine: Advancement of cellular and tissue-based products (CTPs), including allogeneic and autologous skin substitutes, stem cell therapies, and placental tissue matrices designed to directly stimulate healing in stalled wounds.
• Digital Health Integration: Incorporation of connected sensors into dressings and NPWT devices to enable remote monitoring of wound status, temperature, and exudate levels, facilitating early intervention and personalized care plans.
• Point-of-Care Diagnostics: Development of tools for rapid, bedside assessment of wound biomarkers, bacterial load, and perfusion to guide targeted, evidence-based treatment selection.

Future Trajectory and Strategic Considerations

The chronic wound care market is poised for sustained growth, driven by the irreversible demographic trends of population aging and the rising global burden of diabetes. Future evolution will be characterized by a shift from generalized protocols toward personalized wound management, leveraging diagnostic tools to select the most appropriate advanced therapy for a patient's specific wound etiology and biomarker profile.

For industry participants, strategic success will hinge on generating high-quality real-world evidence to support value-based pricing and secure favorable reimbursement. Developing cost-effective solutions for emerging markets, forging partnerships with integrated delivery networks and home health agencies, and creating comprehensive support programs that encompass patient education and adherence will be increasingly important. As the focus on value-based care intensifies, the ability to demonstrate not just product performance but also improvements in patient quality of life and reductions in total cost of care will define market leadership in this essential and growing therapeutic area.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Chronic Wound Care Market Segmentation

• By Type
• Diabetic Ulcers
• Pressure Ulcers
• Venous Ulcers
• Others
• By Product
• Advanced Wound Dressings
• Wound Care Therapy
• Active Therapy
• Others
• By End-User
• Hospitals and Wound Care Centers
• Homecare Settings
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CHRONIC WOUND CARE MARKET BY TYPE

• 5.1. Introduction
• 5.2. Diabetic Ulcers
• 5.3. Pressure Ulcers
• 5.4. Venous Ulcers
• 5.5. Others

6. CHRONIC WOUND CARE MARKET BY PRODUCT

• 6.1. Introduction
• 6.2. Advanced wound dressings
• 6.3. Wound care therapy
• 6.4. Active therapy
• 6.5. Others

7. CHRONIC WOUND CARE MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals and wound care centers
• 7.3. Homecare settings
• 7.4. Others

8. CHRONIC WOUND CARE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Smith and Nephew
• 10.2. Cardinal Health
• 10.3. Coloplast
• 10.4. 3M
• 10.5. Tissue Regenix
• 10.6. Integra Lifesciences
• 10.7. ConvaTec Inc.
• 10.8. Molnlycke Health Care AB
• 10.9. B Braun Melsungen AG.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations